Fuels and chemicals from CO2 SeeO2 Energy Inc. vision is to efficiently convert captured CO2 and/or water to fuels and chemicals using reversible solid oxide fuel cell technology. We provide our customers in the chemicals, metal processing, polymers, and utilities industries with a reliable, onsite and cost competitive industrial feedstocks for their products. ELECTROCHEMISTRY, Solid Oxide Fuel Cells, Solid Oxide Electrolysis Cells, Power to Gas, CO2 to Fuels, Reversible Fuel Cells, Electrolysers, Power to fuels, H2O electrolysis, CO2 electrolysis, and CO2 utilization

Type: Startup Activities: energytech Technologies: Synthetic Biology

Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Tomorrow's Connection Today GENERIS IS A FULL-SERVICE ORGANIZER OF WORLD CLASS BUSINESS SUMMITS We provide leading industry insight, innovative onsite technical and strategic expertise through a platform uniquely designed for executives and professionals to connect. Our experience spans across two decades in successfully developing and delivering high-quality business to business events and services across various industries. Generis was formed with the vision of redefining the way in which knowledge transfer and face to face interactions take place. We see an opportunity to enhance the partnership experience through our understanding of how executives and professionals create and sustain successful relationships. Our …

Type: Startup Activities: healthtech spacetech deeptech biotech transporttech Technologies: Synthetic Biology

Actor of change Immune Biosolutions is a clinical-stage biotechnology company specializing in the discovery and engineering of avian and human antibodies for therapeutic applications. Utilizing cutting-edge technologies, we develop custom immunotherapeutic agents. Our discovery platform efficiently targets complex proteins and generate powerful, specific, and innovative antibodies. Additionally, our antibody production capability allows us to advance our own discovery programs in cancer and autoimmune diseases into the early phases of clinical development. Anticorps, Custom antibody development, Antibody, Développement sur mesure de génération d'anticorps, IgY, Chicken, Poulet, ELISA, Therapeutic Antibodies, Recombinant Antibodies, Humanized Antibodies, GPCRs, and Oncology

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Next generation medical devices. Kenota Health makes allergy testing safe, simple and certain. Kenota Health develops next generation medical diagnostic tools. We make allergy testing safe, simple and certain. Diagnostics, Medical Technology, Point of Care, and Allergy

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Evolution. Adaptation. Future. Phage-based solutions to combat bacteria. - Prevention - Diagnosis - Treatment "One Health" personalized treatments. biotecnología, microbiología, investigación, biomedicina, bacteria, phage, and phage therapy

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Partner of your surgeries Global D is a French company, specialized in the design, manufacture and provision of quality medical devices intended for maxillofacial, pre-implant, orthodontic and dental implantology. Global D, partner of your surgeries. A company of the Menix group Medical Devices, Dental Implants, and Max-Fac Implants

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Imaging all the women Delmont imaging is a company located in La Ciotat, France. Specialized in the design of medical devices for gynecology, our mission is to improve the care and management of all patients, regardless of age and future, by providing innovative, effective and less traumatic solutions. Our products are in line with the general trend of the outpatient surgery and more particularly with the «See & Treat» concepts. Gynecology, Hysteroscopy, and Medical imaging

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop a novel class of medicines with potential to transform the lives of patients with immune mediated diseases. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function and fate coupled to a biomarker discovery effort with potential to bring precision to the treatment of immune-mediated diseases. Launched in 2018 by Third Rock Ventures with a $60 million Series A financing, Rheos is built on groundbreaking science from pioneers in the field, our passionate team of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your partner to resolve inflammation Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Air Liquide Medical Systems is the subsidiary of Air Liquide Healthcare that is dedicated to Medical Devices. The company develops, manufactures and sells innovative products in three fields: ventilation (ventilators and patient interfaces for intensive care, emergency care, transport, home), equipment for medical gases and aerosol therapy. We engage for people who strive for life, by inventing the easiest to use device and transforming the standards of care. We engage to offer a better quality of life to patients. Our values are: innovation, simplicity, quality, engagement and team spirit. dispositifs médicaux, ventilateurs, and masques

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

A pioneer in handheld fundus camera technology with integration to AI. MedTech from Finland, Enabling Screening for All. Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Our AI-powered screening solutions aim to transform diagnostic processes of various diseases, empower early detection, and improve people’s health through innovations. Two decades of pioneering expertise, we design cutting-edge retinal imaging technology that is trusted by healthcare professionals worldwide. Our technology is extensively patented, clinically validated and has approvals in all key markets, including CE, FDA and CFDA. Our products are sold via various sales channels in …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Improving life for amputees through bone-anchored prostheses, healthy soft tissue and relief of phantom limb pain. Integrum has since the start in 1998 been helping individuals with amputations towards an improved quality of life. A thorough experience in osseointegration has generated a system for bone-anchored prostheses – a beneficial alternative to the traditionally used socket prosthesis. Integrum is world leading in this area, with patients from all parts of the world treated in centers of excellence. Performing continuous research and development, Integrum aims at providing safe medical devices and supporting a more active lifestyle for those experiencing limb loss. In …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

One Life One Skin Skin Tech Pharma Group S.L., is a privately held structure, based in Costa Brava, Spain, that results from the merger of three companies having a longstanding and recognized existence in the aesthetic world market. Skin Rebirth S.L. (SKIN TECH), Aesthetic Dermal S.L. (RRS and XL Hair) and Sicosmedd Eurolab S.L. joined their research, production and business abilities to form the new group. This merger allows boosting the development of the different branches of the new group: aesthetic branch, pharmaceutical branch and research/development and manufacture branch. Skin Tech Pharma Group S.L. clusters the distribution channels of the …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

The IV drug-delivery expert Technoflex is the independent leader in the design, production and commercialization of I.V. drug delivery bags (standard or customized) and connectors with FDA and EMEA references. With a devoted R&D team, Technoflex offers a specific high value opportunity of taylored products to its partners.

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Unmask Cancer, Elicit Immune Response Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors. Glyco Immuno Oncology

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

French Manufacturer of Medical Devices for Home Care and Nursing Homes. Pharmaouest Industries, a French manufacturer of medical devices for home care and nursing homes, is today one of the leaders in the supports for the prevention of the tuns. After 40 years of existence, held entirely by family capital Pharmaoust Industries offers a very wide range to: • Home support • community From a perspective of constant progression, Pharmaouest Industries has strengthened its technical and commercial skills with the successive buyouts of Medimo companies in 2004, Bartex in 2010 and Préventix in 2016.

Type: SMB Activities: consumer services healthtech manufacturing Technologies: Synthetic Biology

EQL Pharma AB (publ) is a pharmaceuticals company based out of Skåne County, Sweden.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Curing cancer BIMINI Biotech BV is an innovative biotech start-up that is developing unique compounds for oncology.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Innovating vision RhyGaze AG is pioneering a transformative approach with cone optogenetics, which has the potential to revolutionize vision restoration for patients suffering from blindness. pharmaceutical development, optogenetics, gene therapy, ophthalmology, and pharmaceutical research

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Award-winning cannabis brands & products. Crafted with pride, by people who care. Entourage Health Corp. (previously WeedMD Inc.) is the publicly traded parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders and producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario-based extraction, processing and distribution facility. With the addition of Starseed Medicinal, a medical-centric brand, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Developing bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body. Aspect is creating these next-generation cell therapies by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials. Aspect is advancing a pipeline of bioprinted tissue therapeutics across multiple disease areas in the endocrine and …

Type: Startup Activities: deeptech biotech Technologies: 3D Printing New Materials Synthetic Biology

Helping you create human-relevant in vitro models! Imagine a world where your experiments are cutting-edge, yet straightforward to perform, analyze and interpret, experiments that are time-saving, more accurate and more physiologically relevant. All this so you can get results sooner and move closer to your goal. This world is our vision! We’re committed to developing next-generation technologies for you. Powered by scientists, we design and produce innovative microfabricated devices with feature-sized components that match the dimensions of biological cells, so that you can take full advantage of emerging cell culture technologies, such as stem cells & 3D culture systems. These …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Harnessing The Power Of Clinically Proven Blood Proteins To Help Your Dog Stay Healthy, Active, And With You. WINPRO is the world's first and only line of blood protein supplements. WINPRO products use the power of clinically proven animal blood proteins to help prevent and combat the negative effects of stress-induced inflammation in dogs. Many of today's most common canine health problems are caused by inflammation which is often caused by stress.

Type: Startup Activities: pettech healthtech foodtech Technologies: Synthetic Biology

Enabling our healthcare client partners to accelerate breakthrough cancer solutions. Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies.

Type: Startup Activities: pettech deeptech biotech Technologies: Synthetic Biology

Changing the way cancer is fundamentally treated. ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Our approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. The ELIAS Cancer Immunotherapy (ECI®) works by conditioning the immune system to recognize a patient’s unique cancer, and then delivering an army of activated killer T cells to specifically target and attack those cancer cells. Learn more at eliasanimalhealth.com.

Type: Startup Activities: pettech biotech healthtech deeptech Technologies: Synthetic Biology

Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs. Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to …

Type: Startup Activities: pettech deeptech biotech Technologies: Synthetic Biology

The GestSure System allows surgeons to control operating room computers while scrubbed using simple hand gestures. GestSure Technologies is creating rich, touchless gestural interfaces that allow surgeons and interventional radiologists to control the equipment around them. Our system works as a layer on top of existing PACS, 3D visualization, or electronic medical records. That means no clumsy software to install and no need to import imaging into a parallel system. Gestural Interfaces, Medical Devices, and Health IT

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Genomics Imaging for Precision Medicine Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. Liquid biopsy is a rapidly growing field of significant interest to the medical community for being less invasive and more easily replicated than traditional diagnostic approaches. By combining our team’s considerable expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease-associated genetic instability, Telo Genomics is developing simple and accurate products that improve day-to-day care for …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Made With Empathy THEYA Healthcare designs and manufactures garments that promote healing, offer exceptional comfort and functionality, and look beautiful. Our bras and briefs are clinically proven to have a positive impact on body image, improve quality of life and help heal and alleviate pain. Founded in 2015, Theya Healthcare was originally established to fulfill an unmet need in women's breast cancer health. Our female designers created the original patented bamboo post-surgery bra. To this day, we remain the only post-surgery bra, clinically proven to help women heal and feel better faster after breast cancer surgery. We use the finest …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Service robots for business Promobot is the largest service robotics manufacturer in Europe. We work in the fields of mechatronics, AI, and neural networks. Our developments include autonomous navigation, dialogue systems, manufacturing of artificial skin and muscles. Promobot creates humanoid and service robots, while also engaging with human-machine interaction as a whole. Promobot robots operate in 40 countries around the world. Their line of work includes interaction with people at events, customer assistance, management of internal systems, and patient assessment for hospitals. Robotics, AI, Hardware, Software, Industry, IT, and Engineering

Type: Startup Activities: it services manufacturing Technologies: A.I. A.I. - Deep Learning Robotics Synthetic Biology

My drugs, everywhere, in complete safety 🚀 MyMediks is the leader in specialized drug delivery to individuals and health professionals since 2016 and the 1st specialized network of health deliverers. 🇫🇷 Thanks to our tools and know-how, we support healthcare professionals today in more than 12 French cities to transport drugs safely. 🧑‍💻 For more information: http://www.my-mediks.com Pharmacy, drugs, delivery, health, internet, innovation, startup, business development, transport, patients, transport, e-health, pharmacy, and pda

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Advancing Intratumoral Drug Therapy Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism

Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Framing the future of autoimmune diseases Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Non-invasive white blood cell monitoring Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device. Medical Devices, Diagnostics, Medical Technology, Clinical Imaging, and Bioengineering

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

What If You Could Repair Broken Genes? What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

#AI #biopharma #therapeutics #mitochondrial #proteinhomeostasis #oncology #neurology #raredisease #drugdiscovery BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be …

Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology

Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases. Next-generation CRISPR genome editing, allogeneic CAR-T cell therapies, oncology, and …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bringing you a new generation of health products inspired by marine biodiversity Over the last decade and working with experts and local communities, Sirenas has sustainably and ethically built one of the largest and most unique collections of marine organisms and plants from diverse ecosystems and geographies. From the deep sea to coral reefs and estuaries. We’ve run these samples through cutting edge and proprietary chemical extraction and analytics, and tested each one in over 70 in-vitro biological assays relevant to human health. The result is the largest repository of information connecting the unchartered chemistry of marine organisms to applications …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Build a Heart. Save a Life. Pioneered by accomplished business leaders, guided by world-class biomedical and life science experts, and financed through equity crowdfunding, BIOLIFE4D is driving a movement to transform the treatment of heart disease, the leading cause of death worldwide. Leveraging advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation, this biotech company is committed to optimizing the process and technology around viable human organ replacement, and making it a safe, accessible, commercially viable, and cost-effective reality.

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Ligandal is developing precision molecular therapeutics and targeted delivery technologies. Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies. Given that increasingly complex disease states require precise and custom-tailored medicine, …

Type: Startup Activities: biotech deeptech healthtech nanotech Technologies: Synthetic Biology

Healing is in Our Blood RedDress, a private medical device company, developed a ground-breaking, advanced wound care solution based on a patented technology using a patient's own blood to harness body's natural process to heal wounds. The company based in Israel, was founded in 2009 by Dr. Igal Kushnir, MD and Alon Kushnir and is focused on developing effective solutions that improve patient outcomes. RedDress management has vast experience in bringing breakthrough medical ideas to successful commercialization. wound care, wound healing, tissue repair, chronic ulcers, diabetic foot ulcers, pressure ulcer , venous ulcers, burns, and wound dressing

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Engineer agricultural waste into high-value, low-cost, and scalable biomaterials to end microplastics and hunger. Mi Terro is a venture-backed advanced material company that engineers agricultural waste into high-quality, low-cost, and scalable biomaterials to end microplastics – this is a first-of-its-kind approach. We are excited to see such a significant leap forward in our ability to manipulate nature’s most diverse and abundant building blocks. Our technologies are patented and are USDA Bio-based Certified. Mi Terro uses a selection of biopolymers and natural fibers with the aim of maximizing the use of agricultural side streams (non-food feedstock) and certified biomasses. While bio-based, …

Type: Startup Activities: agritech biotech cleantech deeptech greentech Technologies: Bio sourced materials New Materials Synthetic Biology

Equipment Planning Procurement and Asset Management MTS Health are one of the UK's leading Providers of Clinical Technology Management through our Operational Services Team and the Equipment Advisory Team. MTS has been delivering services to the NHS and Private Sector for over 25 years; with a specialist team of Bio-Medical Engineers, Clinical Scientists; MCIPS Qualified Procurement specialists; PRINCE 2 trained Project Managers and Construction Project Management Interface personnel. MTS Health was founded in 1999 and, in its 25th year, it is now part of Sodexo Health & Care. As a global organisation, Sodexo provides scale, expertise and innovation throughout the …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Transforming Cell Therapy Engineering NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human stem & primary cells. The patented NanoStraw technology provides direct intracellular access into hard-to-transfect stem & primary human cells for efficacious delivery of any cargo. By using a physical, non-perturbative mechanism for delivery, the challenges of viral-based cell manufacturing (time, cost and technical difficulties) are eliminated, resulting in fewer, faster operational steps. For more information on NAVAN, please visit www.navanbio.com.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Inspired by your breath® 💡 French designer of medical devices in the fields of asthma and allergy 📍 Normandy, France 🎓 Company certified ISO 13485:2016, medical device standard The Laboratory OptimHal-ProtecSom is a Norman research SME (Small and Medium-sized Businesses) which designs and manufactures in France medical devices for the lung deposition of medicine, asthma and allergy. The company, which dedicates a third of its resources directly to research, expands in part through an assertive politic of partnership: - Partnerships for the distribution of its devices, currently available in 30 countries through a network of 15 exclusive partners. - Partnerships …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Through neuroscience and engineering, we elevate brain health and performance. Through neuroscience and engineering, we elevate brain health and neural performance with our brain photobiomodulation technology. Published research with our patented technology has produced improvements in cognition, memory and mood. From neurodegeneration to brain performance, we aspire to accelerate photobiomodulation research by collaborating with bright minds globally. neurotechnology, brain photobiomodulation, biohacking, neurofeedback, brain stimulation, wellness technology, alzheimer's research, and traumatic brain injury research

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Advancing orthopaedic surgery by providing surgeons with effective, easy-to-use technology. Intellijoint Surgical delivers cutting-edge navigation solutions for total joint replacements, empowering Orthopaedic Surgeons and their Care Teams with user-friendly, effective technologies. Our product suite includes three innovative solutions: * Intellijoint VIEWTM: A web-based planning tool for functional cup planning and implant templating, eliminating the need for CT imaging. * Intellijoint HIP®: Provides real-time, intraoperative measurements for both primary and revision Total Hip Arthroplasty. * Intellijoint KNEE®: Assists with intraoperative measurements, ensuring precise alignment and bony cuts for optimal implant positioning. All our products are supported by robust clinical evidence, enhancing …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Fastest provider of PFAS sample analysis in the lab and field. FREDsense is the fastest provider of PFAS sample analysis in the lab and field helping developers, operators, and consultants expand screening programs, optimize destruction and remediation efforts, and accelerate PFAS mitigation efforts globally. We apply our decade’s worth of innovative rapid test development for hard-to-detect compounds and parameters and using the power of biology, quickly and affordably help organizations understand exactly what’s in their water. Synthetic Biology, Water Quality Monitoring, Cleantech, Biotechnology, Sensors, Instrumentation, IoT, PFAS, and Analytical Testing

Type: Startup Activities: biotech deeptech greentech water management cleantech Technologies: IoT Sensors Synthetic Biology

Move More, Live Better! Electrotherapy with Tens is scientifically recognized as an effective, safe and complementary solution to medication to control pain. It acts on the natural mechanisms of the body by using electrodes. Our high quality devices are designed in Quebec and approved by Health Canada. They are portable and easy to use at home self -management by patients. We also offer muscle stimulators for healthy muscles and denervated muscles. Our team, made up of members of the professional order of Quebec physiotherapy and specialized in functional electrotherapy, places the patient at the center of pain management and rehabilitation. …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Electro-medic, proud designer of analgesic devices accessible to all There are a multitude of daily, professional or sporting activities, and the body reacts in more or less long term and in a very different way from one individual to another, to each of them. Electro-Medic, proud designer (QC, CA), offers therapeutic devices that are aimed at any user wishing to benefit from a program aimed at a significant reduction in pain and even allowing him, as the case may be, to go about his daily occupations! The use and benefits of electrotherapy The enthusiasm aroused by the use and benefits …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

TREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology …

Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

EHN Canada is the nation's largest network of industry-leading mental health and addiction treatment centres. With over 100 years of collective experience in providing high quality inpatient and outpatient services, EHN Canada provides a comprehensive, compassionate, and truly national therapeutic option to patients, families, healthcare practitioners, and corporate partners. Under the umbrella of EHN Canada, we are able to harness the power of Canada's leading treatment centres for addiction, trauma, and mental health: Edgewood Treatment Center in Nanaimo, BC; Sandstone in Calgary, AB; Bellwood Health Services in Toronto, ON; Gateway Recovery Centre in Peterborough, ON; Clinique Nouveau Depart in Montreal, …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, …

Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Digital Therapeutics for Adolescent Mental Health Limbix is passionate about delivering mental health treatment to young people who need it the most, when they need it the most. Our team is uniquely suited to develop prescription digital therapeutics, as we understand the value of pairing clinical expertise with technological innovation. Our diverse team of clinicians, product designers, researchers, and engineers are all focused on one thing: improving the lives of teens through accessible mental health treatment. Cognitive Behavioral Therapy, Mental Health, Digital Therapeutics, and Digital Healthcare

Type: Startup Activities: healthtech Technologies: Synthetic Biology

ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Antibody for Therapy AbTx is a preclinical stage biotech company developing the next generation of oncology treatments to treat incurable cancers. AbTx platform is developing mAb innovative enzymatic conjugation. Our platform unlock New Frontiers in Medicine to overcome ADC major drawbacks associated targeting solid tumors by generating antibody Fragment Drug Conjugates (FDCs). ADC, Oncology, and drug develoment

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bring to all patients a weight loss solution, efficient, safe and affordable. Slimbeez is a medical devices company that offers an innovative weight loss solution Weight loss and medical device

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Exploratory research program on organs and organoids on chips The Exploratory Research Program Organs and organoids on chip (Med-Ooc) aims to deploy in France a new generation of biological models thanks to the development of organs and organoids on chip (O & amp; OOC). He is co -piloted by CEA, CNRS and Inserm and funded by France 2030. It has a budget of € 48.4M operated by the ANR. Organs and organoids on chips, they are miniaturized devices containing living cells in a controlled microenvironnement. They are able to reproduce the structure, the operation, and the interactions between organs. These …

Type: Research & Education Activities: deeptech biotech Technologies: Synthetic Biology

Our team designs bioactive compounds and chemical tools to explore different areas of health sciences We are team F9 of the IBMM institute in Montpellier, France, also known as IBMM #peptide. Our team designs bioactive compounds and #chemical tools to explore the frontier of #chemistry and #biology. Our lab is situated in the brand new Pôle Chimie Balard research center. Some of our research topics include : - Folded oligomers such as stapled peptides and foldamers - Peptide based polymers and materials for tissue engineering and antimicrobials - Enzyme inhibitors (cancer, antimicrobials, neurodegeneration) - Design of structure guided GPCR ligands …

Type: Research & Education Activities: deeptech Technologies: Synthetic Biology

Powering the future of medicine Since 2006, Akron’s mission is to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to …

Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology

Blood Pressure Intelligence for Global Health At Aktiia, we're at the forefront of revolutionizing blood pressure management and comprehension globally. Harnessing cutting-edge AI-powered algorithms on top of over 300 million data points collected from more than 60,000 active users across the globe, we foster breakthroughs in hypertension comprehension and tailored patient care. Aktiia's CE-marked platform is currently available in seven European markets and approved as a medical device in 44 countries worldwide. And we continue to accelerate our efforts to achieve better health for the world. AI, hypertension, digital therapeutics, healthcare, blood pressure, and patient management

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Clinical stage biotech company developing a new modality of oral biologics that act on cells in the small intestine. Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAXTM, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science Exchange’s supplier orchestration platform harmonizes purchasing, supplier management, and payment processing. Science Exchange is the first purchasing and supplier orchestration platform for life sciences companies. We’re on a mission to streamline and modernize the way R&D organizations and suppliers work together. Our platform harmonizes purchasing, supplier management, and payment processing through one platform and digital marketplace. Whether using our network of 3,800 suppliers with established contracts or syncing existing ones, a simple intake process enables scientists to purchase the services and products they need while workflows and integrations guide them through approvals and compliance requirements. Science Exchange ensures supplier …

Type: Startup Activities: it services Technologies: Synthetic Biology

Extending the ACTIVE life of Animals! AniCell is a biotech company that extends the ACTIVE life of animals with products generated non-invasively from the miracle of birth and used to accelerate regeneration of tissue and bone in injured animals. AniCell Video http://youtu.be/2H8qZLmNChY Cellular Biology, Regenerative Products, Stem Cells, Equine, Biotechnology, and Amnion

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture

Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

A Simple Idea - Simplify Food, Make it Sustainable, Reduce Trade Offs Soylent means complete nutrition— innovative, science-based, and sustainable. We create our products to deliver complete plant based protein, essential nutrients, healthy fats, and slow-burning carbs in convenient and affordable formats that are both good for you and the planet. We carefully select high-quality ingredients to provide complete nutrition. Our company was founded on the principle of reducing trade-offs between nutrition, convenience, and sustainability and we continue to use these principles as guides in our product formulation and ingredient selection. Food Science, Food and Beverage, Nutrition, Health and Wellness, …

Type: Startup Activities: agritech foodtech Technologies: Synthetic Biology

The leading marketplace for cutting-edge medical innovations in maternal, newborn & reproductive health. Maternova, Inc. is the leading trusted resource for cutting edge medical innovations in women's health and newborn health. Governments, Ministries of Health, NGO's and healthcare professionals around the world partner with Maternova to procure trusted and rigorously tested pathbreaking technologies. We have a network of over 50,000 policymakers, clinicians, midwives, and thought leaders as part of our sphere of influence. To learn more about how your organization can work with Maternova, as either a client or manufacturer looking to commercialize your products, please contact us. Learn more: …

Type: Startup Activities: healthtech biotech civictech deeptech Technologies: Synthetic Biology

Breathe better air in your home, office, or anywhere you work, play, laugh, feel, and live. Molekule is creating safer, healthier indoor environments worldwide, starting with our most essential resource: the air we breathe. Molekule's lineup of air purification solutions incorporates their patented photo electrochemical oxidation (PECO) technology, which surpasses traditional filters by effectively destroying a wide range of pollutants including VOCs, mold, bacteria, viruses, and allergens. These devices have undergone rigorous assessments and validations by third-party laboratories, earning FDA clearance as medical devices. It’s all part of Molekule’s vision of changing the world from the indoors out. By using …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Improving the lives of stroke victims by developing tools for early and accurate neurologic assessment. Forest Devices is a medical device startup located in Pittsburgh, Pennsylvania. We are the creators of SignalNED, a fast, reliable, and accurate rapid EEG providing users clear qEEG results. Our mission is to create a better way to detect stroke and make informed decisions that directly lead to an improved quality of life for patients post-stroke and a decreased burden to the healthcare system and patient’s loved ones. Medical Devices

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Spread the warmth, save lives. Warmilu is a warming technology company manufacturing medical devices and products to save lives and provide comfort. We are currently warming over 8,000 infants born to over 35 hospitals based in 16 countries with partners including Doctors Without Borders, Relief for Africa Foundation, Rotary Club, the Hillman Accelerator, UCSF, the University of Michigan, and P&G among others. Together, we can spread lasting warmth to transform lives. Medical devices, Heat therapy, Heat technology, Phase-change technology, Personal care products, Social entrepreneurship, and Home healthcare

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Transforming treatment for cancer inflammation viral infection | Unveiling the Translocon to unlock innovative therapies Enodia Therapeutics, a French biotech company, is advancing first-in-class treatment for cancer, inflammatory diseases, and viral infections by targeting the translocon, a key gateway for protein secretion in the cell. Harnessing a cutting-edge AI-driven approach, we are developing selective small molecule inhibitors that block secretion and promote the degradation of pathological proteins at their source. Emerging from the Institut Pasteur and nurtured by Argobio, Enodia is built on breakthrough science with a singular mission: unveiling the translocon to unlock innovative therapies.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovations from Nature The Austrian Centre of Industrial Biotechnology (acib) replaces conventional industrial processes by new, more ecological and economical methods that are adopted from nature. Therefor acib can rely on 30+ years of experience and a network of 180+ mostly longterm international scientific and corporate partners and 200+ researchers in the multiple disciplines of industrial biotechnology and bioengineering. The acib network meets the needs of of the biotechnological, chemical and pharmaceutical industry and is the preferred partner for competitive research in industrial biotechnology – focused on biocatalysis, enzymes and (pharmaceutical) protein production. acib partners get access to innovative scientific …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Easily detect your biological nanoparticles A spin-off from the Institut d'Optique Graduate School, Université Paris-Saclay, UNVEIL is a deeptech start-up that aims at facilitating the development and production of biologics (drugs derived from living organisms, such as messenger RNA vaccines, as opposed to chemical ones). These biologics (gene therapy, RNA vaccines, etc.) are transported to the target site in the human body by nanometric vectors (viruses or lipid nanoparticles). R&D and production of these biomedicines is hampered by the lack of effective technology to measure vector loading. UNVEIL has developped an optical, label-free instrument capable of quickly and easily measuring …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Aeterna Zentaris is focused on serving the unmet medical needs of patients with rare endocrine diseases Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, MacrilenTM (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). MacrilenTM is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada. Aeterna Zentaris is also …

Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Therapeutic innovations and resistances Inthere research is articulated around the exploration of doses-exposures-effects of antibiotics and internal and external antiparasitaires. Its purpose is to produce innovative solutions which lead to a reduced and optimized use of anti-infectious. The work carried out within Inthere is part of a "One-Health" approach to the interfaces of the man-animal-environment triptych. Inthere is a multidisciplinary unit, the collective of which brings together skills in the fields of biology (microbiology, entomology, parasitology, cellular and molecular biologies), analytical chemistry, pharmacology and mathematics. Inthere welcomes university hospital staff (Faculty of Pharmacy), in connection with the Toulouse University Hospital. …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

A Confident Choice for LifeTM At GC Aesthetics our goal is to empower and support individuals on their body transformation journey. As international aesthetics market leaders, boasting over 30 years industry experience, innovation and continuous improvement rank high as key drivers; when manufacturing our product portfolio. With decades of market presence (*using Nagor and Eurosilicone) and experience in the breast implants industry we have developed: - A strong reputation for safety, quality and reliability. - Innovative product design features. - Focused research and development. - An empathetic and supportive approach to marketing and customer service. Medical Devices, Reconstruction Products, Breast …

Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology

World leader in Elemental & Isotopic Microanalysis CAMECA is a world-leading supplier of high-performance analytical instrumentation and metrology solutions for development, production support, and basic materials research. Our instruments equip prestigious government and university labs as well as leading high-tech industrial companies around the world. Founded in 1929, CAMECA rapidly established its name by pioneering, first Electron Probe Micro-Analysis (EPMA), followed by Secondary Ion Mass Spectrometry (SIMS), and more recently Atom Probe Tomography (APT). Our state-of-the-art production facilities in France and the US allow our experts to develop the most sophisticated micro-analytical tools addressing all kinds of issues from the …

Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology

The ISTCT unit "Imagery and therapeutic strategies for brain cancers and fabrics", UMR6030 is a mixed research unit of the CNRS and the University of Caen-Normandy (Unicaen) hosted at GIP Cyceron in Caen. ISTCT's research activities aim to better understand the pathophysiology of hypoxic tumors (brain-poumon) and identify new therapeutic strategies targeting the tumor and its microenvironnement but also to protect the surrounding healthy fabric of anti-cancer treatments such as radiotherapy. For example, in addition to molecular and/or cellular strategies targeting hypoxia, ISTCT studies the interest of Hadrons (carbon and protons ions) in combination with other therapies (chemotherapy, targeted therapies, …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Make​ your Own Neuronal Network At MicroBrain Biotech, our mission is to revolutionize drug development by embracing ethical and cruelty-free practices, putting humanity at the center of our work, and relentlessly pursuing groundbreaking discoveries. We are committed to creating innovative solutions that improve the quality of life for patients and their families, while treating all living beings with compassion and respect. Through collaboration, scientific excellence, and a commitment to sustainability, we aim to leave a lasting positive impact on the world of healthcare and beyond.

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Shielding life from Radiation CellTereo offers patented cryopreservation technology that shields biological samples from harmful radiation during long-term storage. This includes specialized radiation shielding in cryostats and radiation detection services to maintain the integrity and viability of preserved materials. Supported by: SATT Linksium Grenoble Alpes & Station F, Paris.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology New Materials

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The next generation of of single domain antibodies Emglev is a biotechnology company established in 2023 as a spin-off of Institut Curie dedicated to the discovery and the development of transformative immunotherapies to address unmet medical needs in oncology. By leveraging its unique proprietary platform, expertise and innovative approach, Emglev unlocks the current barriers of conventional antibody discovery to provide unique targets and sdAbs selected fully in vitro and validated for therapeutic applications in any format against any target. At Emglev Therapeutics, we have assembled an experienced, interdisciplinary team with a unique vision : to unlock the next level of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aminogram designs and markets innovative medical devices at La Ciotat in France. Created in 2003, Aminogram designs, produces and markets innovative medical devices for analyzing body composition. Our solutions are recognized for their reliability and practicality and are used both in research and in clinical nutrition. At the forefront of innovation, Biody Xpertzm 3 uses bioelectric impedance spectroscopy technologies (BIS) for non -invasive clinical evaluation and precise monitoring of body composition. This patented 2 in 1 device allows measures with or without cables, offering optimal flexibility. Made in France and certified this class IIA medical medical under MDR regulations, the …

Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

Turning Cancer’s Energy Dependency Against Itself: a Shift in Precision Drug Delivery INATHERYS is a clinical-stage biotech advancing precision drug delivery, turning cancer’s energy dependency against itself. Our lead asset, an ADC targeting CD71/TfR1, is designed to address critical needs in treating proliferative cancers.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Ahead of the Curve Orna Therapeutics is a biotechnology company reshaping RNA therapeutics. We are developing the leading circular RNA technology platform (oRNA®) and unprecedented lipid nanoparticle (LNP) delivery solutions – unlocking the therapeutic possibilities of circular RNA and pioneering the next chapter of safe and effective in vivo therapies for the treatment of disease. Website: www.ornatx.com

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cell therapy Acceleration and Innovation: Rethinking cell & gene therapy By Institut Curie CellAction (Cell therapy Acceleration and Innovation) is the cell and gene therapy platform of the Paris-Saclay Cancer Cluster (PSCC) at Institut Curie. A first in France, CellAction enables collaborative projects to be launched with industrial partners on a national and international scale. The aim is to accelerate the development of optimized cell and gene therapies. CellAction is founded on the centralization of key expertise required for the drug development process: - Institut Curie's highly qualified medical-scientific teams - Cutting-edge technologies for in vitro and in vivo testing …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

AlchiMedics is specialized in the coating of implantable medical devices for interventional cardiology and neurology. AlchiMedics is specialized in the coating of implantable medical devices for interventional cardiology and neurology, and structural heart. It has a specific expertise in building unprecedented coatings showing accelerated re-endothelialization and eliminating thrombosis, thus bringing patient safety to the next level by reducing the need for anti-platelet therapies. About 1.75 million patients, worldwide, are today implanted with devices powered by AlchiMedics’ technology, and growing. Coating, Polymers, Electrografting, Stents, Interventional cardiology, Drug release, Drug Eluting Stent, CD31, Neurological intervention, Coronary, Intracranial, Flow diverters, Anti-thrombotic coatings, re-endothelialization, …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Dyes for Scientific Research and Medical Imaging PROIMAGING develops fluorescent labeling dyes for scientific research and medical imaging. Our core business is to bring to the clinical market innovative molecules that allow imaging tumors sometimes difficult to explore or excise surgically. The objective is to provide a complementary medical service useful for imaging cancers per-operative. At the same time, PROIMAGING develops highly effective dyes for scientific research, particularly for cellular imaging. Our products are photostable, non-cytotoxic, and suitable for long-time imaging on living cells. Some of our molecules are compatible with advanced FLIM and STED imaging techniques. We cover a …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Innovating a New Class of Medicines to Drug the Undruggable InFocus is a discovery-stage biotechnology company dedicated to true innovation for novel therapeutic modalities. We are integrating unique experimental technologies with a state-of-the-art algorithm-driven drug discovery platform, to develop next-generation small molecule drugs against undruggable targets at unprecedented scale.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unlocking the road to precision medicine by tumor characterization via high resolution proteomic profiling. Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal is to unlock …

Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning

Your partner in testing solutions Abich - Lifeanalytics is the Competence Center dedicated to Cosmetics and Medical Devices. Abich laboratories develops new and updated methods on biotechnology field to verify safety and efficacy of cosmetics and medical devices. The Clinical Trials Division also performs tests on healthy volunteers under the supervision of specialised personnel and in compliance with the standards for the sustainability of cosmetic claims and medical devices. Lifeanalytics, part of the CERBA Healthcare Group, was born from the union of 60 Italian companies that have over forty years of experience in analytical services of chemistry, microbiology and biology …

Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Clinical Safety & Efficacy studies for Cosmetics, Medical Devices/OTCs and Nutritional Supplements ZURKO RESEARCH is a Contract Research Organization (Third Party Testing house) established in 2005. We offer a wide range of Clinical Safety & Efficacy studies for Cosmetics, Medical Devices/OTCs and Nutritional Supplements. Zurko Research is a privately held Spanish company with three testing sites in Spain: Madrid, Barcelona and Albacete and one site in New York, USA. With over 100 employees and more than 8,000 studies conducted each year we offer our services to clients in 47 countries worldwide, with a strong presence in Europe and North America. …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

The best Partner to elevate your Business in Health & Personal Care market Complife is a worldwide group, which provides consulting and testing services for cosmetics, food supplements, medical devices, biocides, household products and pharma. Our scientific experts will help you in demonstrating the safety, tolerability and efficacy of products, as well as their chemical and microbiological features. We offer a wide range of analysis and services in the field of microbiology, chemistry, product development, as well as in the regulatory sector, helping you to meet end users’ expectations. Regulatory & Consulting, Pre-clinical studies: in vitro, Analytical chemistry, Microbiology, and …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology